Anzemet

Company
Hoechst Marion Roussel

Approval Status
Approved February 1998

Treatment for
prevention of nausea and vomiting associated with chemotherapy and surgery

Possible similar drugs
Anzemet

Areas
Cancer & Oncology

Anzemet has been approved as an antiemetic that prevents nausea and vomiting associated with chemotherapy and surgery. Anzemet is available in both I.V. and oral formulations.

Anzemet_410 Drug Information

The Anzemet_410 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top